Shanghai RAAS Blood Products Co., Ltd.
002252
Rang in aandelen
#3653
Shanghai RAAS Blood Products Co., Ltd. engages in the research, development,... Shanghai RAAS Blood Products Co., Ltd. engages in the research, development, production, and sale of blood products. It provides human albumin, intravenous injection of human immunoglobulin, coagulation factor products, vaccines, diagnostic reagents, and testing services. The company was founded by Kieu Hoang on October 29, 1988 and is headquartered in Shanghai, China.
Aandeelprijs
$0.70283234
Marktkapitalisatie
$4.63B
Verandering (1 dag)
-0.61%
Verandering (1 jaar)
-25.18%
Land
CN
Handel Shanghai RAAS Blood Products Co., Ltd. (002252)
Categorie
Healthcare
P/S-ratio voor Shanghai RAAS Blood Products Co., Ltd. (002252)
P/S-ratio op October 2026 TTM: 4.95
Volgens de meest recente financiële rapporten en aandelenkoers van Shanghai RAAS Blood Products Co., Ltd. is de huidige P/S-ratio (TTM) 4.95. Eind 2023 had het bedrijf een P/S-ratio van 6.32.
P/S-ratiohistoriek voor Shanghai RAAS Blood Products Co., Ltd. van 2005 tot 2026
P/S-ratio aan het einde van elk jaar
| Jaar | P/S-ratio | Wijzigen |
|---|---|---|
| 2026 (TTM) | 4.95 | -15.67% |
| 2024 | 5.87 | -7.18% |
| 2023 | 6.32 | -2.84% |
| 2022 | 6.51 | -39.30% |
| 2021 | 10.72 | -40.64% |
| 2020 | 18.06 | 24.22% |
| 2019 | 14.54 | -32.54% |
| 2018 | 21.56 | -57.21% |
| 2017 | 50.37 | 3.81% |
| 2016 | 48.52 | -10.78% |
| 2015 | 54.39 | 37.05% |
| 2014 | 39.68 | -59.96% |
| 2013 | 99.10 | 393.29% |
| 2012 | 20.09 | -11.65% |
| 2011 | 22.74 | -41.89% |
| 2010 | 39.13 | 27.96% |
| 2009 | 30.58 | 34.41% |
| 2008 | 22.75 | 41.59% |
| 2007 | 16.07 | 149.43% |
| 2006 | 6.44 | 8.58% |
| 2005 | 5.93 | 0.00% |
P/S-ratio voor vergelijkbare bedrijven of concurrenten
| Bedrijf | P/S-ratio | Verschil in P/S-ratio | Land |
|---|---|---|---|
| 10.02 | 102.45% |
US
|
|
| 40.55 | 719.14% |
US
|
|
| 3.96 | -19.98% |
AU
|
|
| - | - |
CH
|
|
| 10.15 | 104.96% |
NL
|
